课题基金 / 基金详情

GENE EXPRESSION IN PEDIATRIC ARTHRITIS

GENE EXPRESSION IN PEDIATRIC ARTHRITIS
小儿关节炎中的基因表达
批准号:
7608241
负责人:
BETH S GOTTLIEB
金额:
$2.88万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

BETH S GOTTLIEB的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的主要目的是建立幼年类风湿性关节炎和幼年脊柱关节病(JRA/JspA)的遗传学基础,这是儿童最常见的慢性关节病。该方法将使用综合基因组学来确定可能具有遗传基础的3个因素--易感性、临床结果和治疗反应。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to establish the genetic basis for juvenile rheumatoid arthritis and juvenile spondyloarthropathy (JRA/JspA), the most common chronic arthropathies of childhood. The approach will use integrated genomics to identify 3 elements that are likely to have a genetic basis-susceptibility, clinical outcome, and responses to treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: TRIAL OF EARLY AGGRESSIVE TREATMENT IN JUVENILE IDIOPATHIC ARTHR
CLINICAL TRIAL: STUDY OF RILONACEPT IN THE TREATMENT OF SYSTEMIC JUVENILE IDIOPA
CLINICAL TRIAL: BIOLOGY AND USE OF TNF INHIBITION IN CHILDREN WITH JUVENILE IDIO
CLINICAL TRIAL: TRIAL OF EARLY AGGRESSIVE TREATMENT IN JUVENILE IDIOPATHIC ARTHR
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data